Introduction {#s1}
============

To mediate colonization of host and/or environmental habitats, Gram-negative bacteria encode a highly conserved family of adhesive pili called chaperone-usher pathway (CUP) pili. Notably, CUP pili are critical virulence factors in a wide range of pathogenic bacteria, including *Escherichia, Klebsiella, Pseudomonas, Haemophilus, Salmonella* and *Yersiniae* genera ([@bib56]). To date, 38 distinct CUP pilus types have been identified in *Escherichia* and *Shigella* genomes and plasmids, each of which is hypothesized to promote bacterial colonization of a distinct habitat ([@bib56]; [@bib82]). Interestingly, single *Escherichia coli* genomes carry up to 16 distinct CUP operons, suggesting that the retention of an assortment of CUP pilus types by a single strain may be necessary to accommodate the complex lifecycle of *E. coli* ([@bib82]).

Arguably, the best-studied CUP pili are those encoded by uropathogenic *E. coli* (UPEC), which is the causative agent of the majority of urinary tract infections (UTIs). UTIs affect 150 million people annually worldwide and are associated with significant morbidity and economic impact ([@bib26]). UTI treatment failure is common, with \~25% of woman suffering from recurrent UTI (rUTI), and is due, in part, to the increasing prevalence of drug-resistant UPEC strains ([@bib64]; [@bib84]). UPEC that infect the urinary tract often originate from the host gastrointestinal tract. After being shed from the gut in the feces, UPEC can colonize peri-urethral or vaginal areas and subsequently ascend through the urethra to the bladder and/or kidneys, instigating UTI. In mice, type 1 pili, which promote binding to mannosylated proteins, play critical roles in both the gut and urinary tract. Recent work has revealed that type 1 pili help mediate UPEC intestinal colonization, thus promoting the establishment and/or maintenance of the UPEC reservoir in the gut that can eventually seed UTI ([@bib68]). Upon entering the bladder, type 1 pili facilitate bacterial colonization and subsequent invasion into epithelial cells lining the bladder lumen ([@bib55]; [@bib52]). Bladder invasion is a critical step in UPEC pathogenesis, allowing the bacteria to replicate in a niche protected from innate immune defense mechanisms, antibiotics, and expulsion during urination. UPEC that cannot invade the urothelium, like those lacking type 1 pili or its associated adhesin, FimH, are quickly cleared from the bladder, emphasizing the importance of type 1 pili mediated host-pathogen interactions on the fitness of UPEC during cystitis ([@bib80]). After invading into a bladder cell, UPEC escape into the host cell cytoplasm and replicate to form biofilm-like intracellular bacterial communities (IBCs) ([@bib5]; [@bib38]) comprised of \~10^4^ cells ([@bib81]). Mouse models of UTI have revealed that while some mice are capable of self-resolving acute UPEC infection, others progress to chronic cystitis, which is characterized by persistent high titer bacteriuria (\>10^4^ CFU/ml) and high bacterial bladder burdens (\>10^4^ CFU) two or more weeks after inoculation ([@bib32]). In the absence of antibiotic treatment, chronic cystitis can also be observed in women ([@bib51]; [@bib24]).

*E. coli* strains, including UPEC, are grouped into distinct clades (e.g., clades A, B1, B2, D, and E) based on their genetic relatedness ([@bib74]). While UPEC strains tend to be genetically heterogeneous the majority of UPEC strains isolated from women with UTI in the USA reside in the B2 clade ([@bib65]). While the types of CUP pilus operons encoded in *E. coli* genomes varies between different clades and individual strains, the vast majority of sequenced *E. coli* strains, including nearly all sequenced UPEC clinical isolates, carry an intact copy of the type 1 pilus ([@bib82]; [@bib65]). Type 1 pili are encoded by the *fim* operon which, like the gene clusters encoding other CUP pili, encodes all the dedicated proteins necessary to assemble a mature pilus onto the bacterial surface, including: an outer-membrane pore-forming usher protein, a periplasmic chaperone protein, pilus subunits, and the tip adhesin protein. Most pilus tip adhesins, including the FimH adhesin, are made up of two domains, an N-terminal lectin domain, which is responsible for recognition and attachment to a ligand(s), and a C-terminal pilin domain, which connects the adhesin to the bulk of the pilus ([@bib36]). Pilus subunits, including the pilin domain of the adhesin, are comprised of an incomplete immunoglobulin (Ig)-like fold, which lacks the C-terminal β-strand and require the action of the dedicated periplasmic chaperone for proper folding ([@bib62]). In a process known as donor strand complementation (DSC), a periplasmic chaperone templates subunit folding by transiently providing one of its β-strands ([@bib61]). Chaperone-subunit complexes are then delivered to the outer membrane usher, which catalyzes pilus assembly *via* a reaction known as donor strand exchange (DSE). In DSE, the strand donated to a nascent subunit by the chaperone is replaced by the N-terminal extension (Nte) of an incoming subunit ([@bib62]).

Following this pattern, the type 1 pilus usher (FimD) and chaperone (FimC) help type 1 pili assemble into a composite pilus structure consisting of a short tip fibrillum made up of the adhesin protein (FimH) and two minor subunits (FimG and FimF) that is joined to the pilus rod, a homopolymer of \~1000 FimA subunits. Once extruded to the extracellular surface, the type 1 pilus coils into a rigid right-handed helical structure that is capable of unwinding into a flexible linear fiber ([@bib1]; [@bib37]; [@bib63]; [@bib10]). This ability to transition between a coiled, helical rod and a linear fiber has been proposed to allow the type 1 pilus to act as a 'molecular spring' to maintain adherence in the face of fluid shear forces ([@bib83]). Specifically, we hypothesize that in the absence of urine voiding, the type 1 pilus rod is maintained in the coiled helical state that permits subsequent contact and invasion into bound epithelial cells. However, upon encountering the shear forces associated with micturition, the pilus extends to the linear form, absorbing the shear force and thus preventing the expulsion of the bacteria from the bladder.

Here, using high-resolution cryo-electron microscopy (cryo-EM), we solved the structure of the type 1 pilus rod. Residues involved in critical FimA-FimA interactions were identified that when mutated reduced the force required to unwind the helix, despite not altering the ability of the FimA protein to be incorporated into the pilus rod. When introduced into the chromosome of UTI89, a human UPEC clinical cystitis isolate, these point mutations dramatically reduced the ability of UTI89 to establish an intestinal reservoir and cause acute and chronic cystitis. In contrast, these point mutant strains did not result in large scale differences in levels of piliation or ability to agglutinate mannose-expressing guinea pig red blood cells in vitro. Taken together our results show that the identity of residues within the FimA rod, are critical for the type 1 pili mediated virulence of UPEC in the urinary tract and suggest that the helical pilus rod has an important functional role, beyond serving as a platform to present FimH, in promoting colonization in the gut and infection of the bladder.

Results {#s2}
=======

Determination of the type 1 pilus rod structure {#s2-1}
-----------------------------------------------

To characterize FimA polymers that form the type 1 pilus rod, we solved the cryo-EM structure of native type 1 pili appearing in a preparation of recombinantly expressed Type IV pili (T4P) from the *E. coli* K12 strain BW25113. As shown in [Figure 1A](#fig1){ref-type="fig"}, three types of filaments could be separated by eye: T4P, flagellar filaments, and a third class that were thicker and more rigid than T4P but thinner than the flagellar filaments. Sequencing the *fimA* PCR product showed that the encoded amino acid sequence was identical to the FimA protein from BW25113 (GenBank AIN34588.1) and MG1655 (GenBank NP_418734.1). There was no possibility of cross-contamination of the FimA and T4P filament images, as each has a very different helical symmetry. Averaged power spectra from FimA filaments ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}) showed no trace of the Type IV pilus spectrum ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}).

![Cryo-EM Structure of Type 1 pili.\
(**A**) An electron micrograph of type 1 pili in vitreous ice, surrounded by type 4 pili and flagellar filaments. (**B**) Side view, (**C**) interior view (the front half of the reconstruction has been removed) and (**D**) top view of overall reconstruction of FimA rod with subunits along the same left-handed 3-start helix colored in either blue, salmon or green. (**E**) Close-up view of donor strand complementation (DSC) in the central lumen showing that the β-strands in the reconstruction are very well resolved.](elife-31662-fig1){#fig1}

The FimA reconstruction had an overall resolution of 4.2 Å ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}), which is sufficient to build an atomic model of the structure ([@bib18]). There were no ambiguities in threading the known FimA sequence through the density map ([Supplementary file 1](#supp1){ref-type="supplementary-material"}), even though the electron density observed on the outside of the rod is less well defined ([Figure 1B](#fig1){ref-type="fig"}). As a result, the first two residues and the last residue of FimA, which are located close to each other on the outside of the rod, are not resolved in the density map. The 4.2 Å estimate of the resolution is consistent with the well-separated β-strands and the density present for certain bulky side chains in the central lumen ([Figure 1C--E](#fig1){ref-type="fig"}). Further, in the structure we observe the N-terminal donor strand of one subunit completing the β-sheet of the adjacent subunit. Overall, the type 1 pilus is a 70 Å diameter rod where each adjacent subunit rotates around the helical axis by 115° and translates along the axis by 7.7 Å ([Figure 2A](#fig2){ref-type="fig"}). If we label each subunit along the 1-start helix by N, a subunit N~0~ interacts with six adjacent subunits (N~-1~,N~-2~,N~-3~,N~+1~,N~+2~,N~+3~) ([Figure 2A,B](#fig2){ref-type="fig"}). The donor strand complementation involves mostly hydrophobic interactions. Most prominently, the hydrophobic amino acids Val5, Val10 and Phe12 in the N-terminal β-strand (Nte) of one subunit are inserted into the next subunit's hydrophobic groove created by a missing β-strand ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}).

![Subunit interface of the FimA rod.\
(**A**) Surface view of FimA rod model with subunits numbered along the right-handed 1-start helix. Each subunit is in a different color. (**B**) Ribbon representation to illustrate the interface of subunit N~0~ (in salmon) with neighboring subunits.](elife-31662-fig2){#fig2}

Further, residues corresponding to FimA~BW25113~22--33, which are part of the interior surface of the rod helix, show structural differences between our cryo-EM rod structure and the previously solved crystal structures of FimA ([@bib14])([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). In the DSC interaction of the FimA-FimC complex FimA residues 22--25 form a β-strand interaction with residues 59--56; and residues 31--33 form β-strand interactions with the FimC chaperone residues 102--104 ([@bib14]). Further, within a self-complemented DSE structure FimA residues 29--33 form a β-strand interaction with the appended Nte residues (9-13) ([@bib77]). Within the cryo-EM rod FimA structure, residues 25--29 adopt a helical conformation and residues 30--33 form a β-strand interaction with residues 10--13 from the Nte of the next FimA subunit. These residues form the center strand within the hollow helical core, and thus the ability of this region to adopt multiple conformations may be necessary in order for FimA to function as the major rod subunit.

Comparison between P and type 1 pili {#s2-2}
------------------------------------

The interface between subunits N~0~ and N~+3~ is extremely important in maintaining the FimA helical rod. Previously, two atomic models (PDB ID: 2N2H and 2MX3) for the type 1 pilus have been generated using the same solid-state NMR data ([@bib31]), with the helical symmetries for these models shown in [Supplementary file 2](#supp2){ref-type="supplementary-material"}. The results were described as being FimA from uropathogenic *E. coli* (UPEC) ([@bib31]), however, the sequence corresponds to that of *E. coli* K12 strains, as does the recent FimA cryo-EM structure ([@bib34]) that is also described as being from UPEC. When subunit N~0~ is superimposed between our cryo-EM model with a subunit in 2N2H and 2MX3, significant differences can be seen in the interface with subunit N~+3~ in the different models ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}). The overall RMSD between C~α~ atoms of subunit N~+3~ in our cryo-EM model and 2N7H is 5.7 Å ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}), while it is 11.0 Å with 2MX3 ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}). Between 2MX3 and 2N2H, the overall RMSD is 5.6 Å for subunit N~+3~ when subunits N~0~ are aligned ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}).

Comparison of our type 1 pilus model with the P pilus structure ([@bib33]) shows an interesting difference: in the P pilus, residues 1--5 are fully ordered and make a 90° bend to form a 'staple' which involves contacts with two other subunits ([Figure 2---figure supplement 3](#fig2s3){ref-type="fig"}). In contrast, the first two residues are disordered in our type 1 pilus rod, and the remaining three residues in this region project straight out of the structure and make no contacts with other subunits ([Figure 2---figure supplement 3](#fig2s3){ref-type="fig"}).

Conservation and variability of FimA sequences {#s2-3}
----------------------------------------------

To explore the variation and evolution of FimA, we examined a set of 1,872 FimA protein sequences in the Ensembl Bacteria database ([@bib42]) ([Supplementary file 3](#supp3){ref-type="supplementary-material"}). After filtering to remove protein sequences that are expected to be non-functional and trimming of the signal sequence, the remaining 1,828 protein sequences were aligned. Here, we found that many of the FimA sequences were comprised of 159 residues, including BW25113, while other FimA sequences, such as the one from UTI89, a prototypical UPEC isolate, contained an additional two amino acid residues at the N-terminus of the mature protein ([Figure 3A](#fig3){ref-type="fig"}). Global alignment revealed a consensus sequence of 161 residues where half of the FimA residues in the mature protein are invariant (79/161 residues) and that 83.9% are highly conserved (139/161 residues with \>95% sequence identity) ([Figure 3A](#fig3){ref-type="fig"}). We found the FimA sequences to be significantly more variable than other parts of the type 1 pilus machinery. For example, the mature forms of the FimC chaperone and FimH adhesin (n = 1,760 and n = 1,943, respectively; [Supplementary file 4](#supp4){ref-type="supplementary-material"}) obtained from the same database contain 97.6% and 97.5% highly conserved residues, respectively, as compared to 83.9% in FimA. In general, most *E. coli* genes evolve slowly ([@bib48]), so the degree of divergence between alleles of FimA is abnormally high. This suggests that the selection forces acting on the FimA protein are different from the forces acting on the rest of the *fim* operon. Interestingly, the non-conserved residues within the FimA sequences are all located on the exterior surface of the solved cryo-EM model ([Figure 3B](#fig3){ref-type="fig"}), which is likely indicative of immune pressures selecting for antigenic diversification ([@bib79]). In particular, the first few amino acids of the N-terminus of the mature protein, disordered in our reconstruction, have some of the highest variability throughout the entire protein, suggesting that these amino acids do not play a functional role in the dynamics of unwinding in the type one pilus rod. In contrast, almost every residue involved in subunit-subunit interactions in the rod is either highly conserved or invariant ([Figure 3B,C](#fig3){ref-type="fig"}). This includes every residue lining the lumen ([Figure 3C](#fig3){ref-type="fig"}). The conservation of residues lining the lumen might be due to the transport of some product through this opening that is \~15 Å across (the height of the triangular lumen that rotates as one travels along the pilus). More likely, however, every residue in the lumen is either involved in making a subunit-subunit contact (including the DSE contacts with the Nte from an adjacent subunit) or packed tightly between residues that are making such contacts.

![FimA conservation and variability.\
(**A**) Conservation, consensus amino acid identity, and selection pressures on residues within the mature form of the FimA protein measured by alignment of 1,828 sequences. Numbering here is based on FimA from BW25113 and the vertical dashed line indicates the location of the two amino acid residues, in red, that are present in some FimA sequences. Consensus amino acid residues are shown at each position. Height of the residues corresponds to their information content (bits) where the larger size indicates greater certainty that residue shown is the consensus residue at that position. The vertical bars represent the proportion of strains with the consensus amino acid (0--100%). Vertical bars are colored by selection pressure acting upon the amino acid position, with red and blue bars indicating residues with codons under adaptive and purifying selection, respectively, as measured by a χ^2^ (chi-squared) test. Green bars indicate codons with too little variability for evolutionary analysis and grey indicates amino acid positions that do not show statistically significant evidence for selection. (**B,C**) The degree of conservation for every FimA residue shown in (**A**) has been mapped onto a single subunit in our rod model. The absolutely conserved residues are in blue, the residues that are 40% conserved (the greatest degree of variability found) are in white, and light blue represents 90% conservation. Every residue facing the lumen is 100% conserved. Overall, FimA displays strong signals of purifying selection resulting in conservation with hotspots of adaptive selection resulting in variability of surface residues.](elife-31662-fig3){#fig3}

To examine the importance of FimA-FimA interactions on bacterial pathogenesis, we chose to investigate how mutations in the *fimA* sequence of BW25113 altered functional and mechanical characteristics of type one pili. In addition, to assess whether FimA mutants altered the type-1 mediated ability of UPEC to infect the bladder and colonize the gut, we made mutations in the chromosomal *fimA* gene of UTI89. Thus, we do note that FimA~UTI89~ differs from our cryo-EM rod FimA~BW25113~ sequence in 16 residues, with all of the differences lying within highly variable residues located on the exterior of the pilus rod, including two additional amino acids at the N-terminus. These two additional N-terminal residues in UTI89 generate a shift in the numbering of UTI89 residues compared to FimA~BW25113~ (e.g., A22R in BW25113 corresponds to A24R in UTI89). To avoid confusion herein all residues are discussed using the BW25113 numbering system.

Evidence of evolutionary pressures on FimA {#s2-4}
------------------------------------------

To evaluate the evolutionary pressures shaping FimA and thus the type one pilus rod, we obtained gene sequences encoding the 1,828 FimA proteins from the Ensemble database to measure the selection pressures acting on the gene. After removing incomplete and duplicate sequences from the analysis, we were able to compare a total of 191 unique *fimA* sequences ([Supplementary file 3](#supp3){ref-type="supplementary-material"}), which were then trimmed to remove the signal sequence. These sequences encoding the mature protein were examined for evidence of recombination, which can result from horizontal transfer of genetic sequences between distinct strains and confound evolutionary analyses that assume all sequences were vertically inherited ([@bib9]). Phylogenetic trees were thus corrected for use in subsequent analyses ([@bib46]). We then assessed the ratio of the rates of nonsynonymous (*dN*) to synonymous nucleotide mutations (*dS*) in each codon in the alignment (*dN*/*dS*) to estimate the selection pressures acting on each residue in the FimA protein using a fixed-effects likelihood measurement algorithm ([@bib44]). In general, a *dN*/*dS* ratio \>1 is indicative of selection pressure favoring change in amino acid identity at the position (i.e., adaptive or positive selection) while a *dN*/*dS* ratio \<1 indicates conservation at the codon (i.e., purifying selection or negative selection). Here, we found that 66 codons were under purifying selection, five codons were under adaptive selection, and an additional 27 codons were too conserved to be included in analysis ([Supplementary file 5](#supp5){ref-type="supplementary-material"}). The remaining 63 codons showed no evidence of statistically significant selection in either direction. All of the positively selected sites, N64, A109, T117, S120 and F138, encode residues located on the exterior surface of the FimA rod and away from any subunit-subunit interface ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). The 66 codons under purifying selection combined with the 27 codons too conserved for analysis encode many of the highly conserved residues found throughout subunit-subunit interfaces with the subunits above, below, and alongside ([Figure 3B,C](#fig3){ref-type="fig"}). This strongly suggests that evolutionary pressures are working to conserve the identity of residues that interact within the helical rod, while diversifying amino acid residues that are exposed to the host and susceptible to immune recognition.

To more specifically determine if variation in FimA correlated with *E. coli* clades or pathogenic lifestyles, such as uropathogenicity, we examined the diversity and distribution of the *fimA* gene in a curated set of 67 *E. coli* genomes. This dataset included 21 distinct UPEC strains isolated from a cohort of women with frequent, recurrent UTI and 46 reference *E. coli* strains that included lab and commensal strains, as well as a variety of intestinal and extra-intestinal pathogens ([@bib65])([Supplementary file 6](#supp6){ref-type="supplementary-material"}). The *fimA* gene was carried by the majority of *E. coli* strains analyzed (57/67); including nearly every UPEC strain (96.3% or 26/27 strains). Importantly, the *fimA* sequences from UPEC strains were spread through the phylogenetic tree, indicating that there was not a single variant of FimA found in all UPEC strains ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). To determine if these different variants were under different selection pressure, we measured the *dN*/*dS* ratio of each branch in this *fimA* phylogeny to see if there were branches that were under different selection pressures than the rest of the branches in the phylogeny (i.e., the 'background' rate of selection)([@bib45]). Here, we identified three branches with statistically significant evidence of episodic diversifying selection, including two branches carrying most of the clinical UPEC strains (branches labeled A and B) as well as enterohemorrhagic and enterotoxigenic *E. coli* strains in the branch labeled C ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). This pattern of evolution is indicative of strong adaptive selection acting on some, but not all, branches in a phylogeny. Taken together, we find that *fimA* is much more diverse than other parts of the type 1 machinery, owing to high rates of nucleotide polymorphisms and genetic recombination, and that *fimA* has undergone repeated rounds of strong selective pressures that have conserved residues responsible for subunit-subunit interfaces while varying the external surface of the protein that is exposed to the host milieu.

Analysis of the effect of FimA mutations on Pilus expression and function in vitro {#s2-5}
----------------------------------------------------------------------------------

To determine which FimA residues are required to form the helical rod, we constructed single amino acid codon mutations in the BW25113 *fimA* gene, which were subsequently cloned into the expression vector, pTRC99a ([@bib3]). Residues were changed to either Arginine or Glutamine to insert large charged residues that would promote disruption of FimA interactions without making the surface more hydrophobic. We expressed these variant *fimA* genes in trans in UTI89-LON∆*fimA*, a strain with a chromosomal deletion of the *fimA* gene in a UTI89 strain where the phase-variable *fimS* promoter is locked in the ON orientation (LON) by altering the left inverted repeat necessary for promoter inversion ([@bib47]). This strain transcribes the *fim* operon constitutively, which removes the possibility that differences in type 1 pili assembly/function are due to effects on phase variation by the mutants.

We assessed the function of the type 1 pilus in each *fimA* mutant by measuring the agglutination of guinea pig red blood cells (GP-RBCs). Most of our *fimA* mutants showed hemagglutination (HA) titers similar to the wild-type (WT) *fimA* ([Supplementary file 7](#supp7){ref-type="supplementary-material"}). However, several mutations (A25R, V32R, V65R, V85R, and P145R) abolished the production of adhesive pili ([Supplementary file 7](#supp7){ref-type="supplementary-material"}). This suggests that these mutations, which are located in areas of high conservation throughout the FimA monomer, may disrupt critical interactions with FimC or FimD or may not be able to correctly fold, thus preventing the assembly of the pilus. Notably, each of these residues was either under strong purifying selection pressure (A25, V85 and P145) or was too conserved for evolutionary analysis (codons for V32 and V65 displayed no synonymous mutations and extremely limited non-synonymous mutation rates), which emphasizes their importance in assembly of the type 1 pilus rod ([Figure 3A](#fig3){ref-type="fig"}). Expression of some mutant *fimA* genes, particularly V5R, E45R, E121R and A142R, resulted in a bacterial clumping phenotype when grown in static culture. D62R and D114R also instigated bacterial clumping, but to a lesser extent. Three of these substitutions, E45R, E121R and A142R, are found in residues with relatively high variability in our analysis of FimA sequences, with just 33.9%, 62.3%, and 52.1% sequence identity, respectively. Further, we found that two of these residues (V5 and D114) showed statistically significant evidence of strong purifying selection ([Figure 3A](#fig3){ref-type="fig"}, [Supplementary file 6](#supp6){ref-type="supplementary-material"}).

To measure the impact of FimA~BW25113~ variants produced by the UTI89-LON∆*fimA* strain on pili force-extension responses, we chose six FimA mutant strains that did not disrupt pilus formation or produce severe bacterial clumping in vitro (A22R, A92R, D114R, D62R, K155R and P132R) and applied optical tweezers ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). Since type 1 pili are assembled from FimA subunits into a helical coil, they normally extend in three force phases: linearly increasing, constant force, linearly increasing -- where the characteristic constant force originates from sequential unwinding of subunits (region between the dashed lines in [Figure 4A](#fig4){ref-type="fig"}). The characteristic constant force extension enables the clear identification of instances where multiple pili are attached to a single microsphere, thus enabling us to determine the unwinding force of a single pilus ([Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}). The unwinding force directly relates to the strength of layer-to-layer interactions (e.g., between subunits N~0~ and N~+3~), thus any changes in these interactions caused by mutations would shift the magnitude of the force plateau. To investigate this, we first measured unwinding force of single pili in the strain expressing WT FimA and subsequently examined the force response for each *fimA* mutant. The unwinding force of WT pili was 30.3 ± 0.2 pN (mean ±standard error (SE)) whereas all mutants showed a reduction in the force required for pilus unwinding ([Figure 4B](#fig4){ref-type="fig"}). The unwinding force measured for WT type 1 pili in this study is similar to what has been reported in the literature ([@bib7]). In particular, the A22R variant showed the largest reduction in the unwinding force, 11.2 ± 0.2 pN. We can explain this by the fact that Ala22 in our rod model is tightly packed against Ala93 from another subunit and Val37 from a third subunit ([Figure 4C](#fig4){ref-type="fig"}). Thus, replacing a small alanine with a long arginine side chain is expected to disrupt this interface.

![Mutations to FimA alter the force required to unwind the pilus.\
(**A**) Force response of a single type 1 pilus. The force response is composed of three phases, elastic stretching of the shaft, unwinding of the shaft, and elastic stretching of individual subunits in an open coil. (**B**) Bar chart showing the average unwinding force of FimA~BW254113~ wildtype (WT) and mutants expressed in trans in UTI89-LON∆*fimA* (**C**) Ala22 (cyan) plays an important role in the inter-subunit contacts through interacting with Val37 (magenta) from a second subunit and Ala93 (green) from a third subunit. (**B**) Bar chart showing the average unwinding force of measured pili where the error bars represent the standard error of the mean \[WT, 30.3 ± 0.2 pN, N = 13, 2 replicates; A22R, 11.2 ± 0.2 pN, N = 25, 2 replicates; A92R, 24.6 ± 0.3 pN, N = 19, 2 replicates; D114R, 25.6 ± 0.3 pN, N = 16, 2 replicates; D62R, 26.7 ± 0.4 pN, N = 16, 2 replicates; K155R, 23.6 ± 0.3 pN, N = 14, 2 replicates; P132R, 24.1 ± 0.3 pN, N = 15, 2 replicates\]. All replicates biological. \*\*\*\*p\<0.0001 by unpaired, two-sided t-test).](elife-31662-fig4){#fig4}

FimA mutants alter UPEC pathogenesis in the bladder and colonization of the gut {#s2-6}
-------------------------------------------------------------------------------

In the bladder, type 1 pili are required for binding and invasion of UPEC into superficial facet cells that line the bladder lumen and for the formation of intracellular bacterial communities (IBCs) during the first 6--18 hr of acute infection. This has been shown to be critical for ongoing infection in both humans and mouse models of cystitis ([@bib67]). To determine if mutations in the FimA sequence altered UPEC pathogenesis in relevant mouse models, we constructed UTI89 strains with clean single codon mutations in the chromosomal *fimA* gene (with the phase-variable *fimS* promoter intact). For these studies, we chose to investigate the effects of four FimA mutants that were examined via optical tweezers. Each of these mutations were made in the codon of a highly conserved amino acid positions of FimA~UTI89~ (A22, D62, D114, and P132).

When compared to a strain with the reintegrated WT UTI89 *fimA* sequence, we found that all reintegrated FimA mutant strains demonstrated similar levels of GP-RBC agglutination, in vitro ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}), despite some variability in the level of piliation between FimA mutant strain ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). Interestingly, those mutants that show some increased hemagglutination in the presence of exogenous mannose compared to the WT strain correlated with those that showed some clumping in culture. Overall, these findings indicate that the FimA mutations, which reduced the unwinding force of the rod, do not prevent the expression or function of type 1 pili in vitro.

We next investigated how each mutant altered the kinetics of bladder infection during competitive infections with WT UTI89 over 28 days. In mice that developed chronic cystitis (defined as the development of persistent high titer (\>10^4^ cfu/ml) bacteriuria and high titer (\>10^4^ cfu/ml) bladder bacterial burdens at sacrifice \>4 weeks post-infection), strains producing FimA~UTI89~ variants with the D62R, D114R, and A22R substitutions were outcompeted by up to six logs by the reintegrated WT strain ([Figure 5A--E](#fig5){ref-type="fig"}). The FimA P132R variant had no effect on the ability of the strain to compete with the WT strain in chronically infected mice ([Figure 5B](#fig5){ref-type="fig"}). Mice that resolved their infections (defined as any animal whose urine or bladder titers dropped below 10^4^ cfu/ml at least once during the 4 week infection) in this experiment are shown in [Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}.

![Point mutations in FimA alter UPEC pathogenesis in the bladder.\
C3H/HeN mice were concurrently transurethrally inoculated with 1 × 10^8^ CFU of wildtype (WT) UTI89 and one of four isogenic UTI89 strains containing point mutations in the *fimA* gene. (**A--E**) Longitudinal urinalyses were performed over 28 days and examination of UTI89 and FimA mutant titers in bladders and kidneys were determined at time of sacrifice (28 dpi). (**F**) Mice were also infected singly, via transurethral inoculation, with UTI89 or FimA mutant strains. Longitudinal urinalysis was perfomed over 28 days ([Figure 5---figure supplement 3](#fig5s3){ref-type="fig"}). Bladders titers taken at 28 dpi after single infections are shown in panel F along with the percentage of mice that developed chronic UTI (% chronic) along with the number of mice used in the study (**N**). (**G**) Number of intracellular bacterial communities (IBCs) formed by indicated strain at 6 hr post infection (hpi). (**H**) Mice were singly infected with WT or A22R mutant and the ability of each strain to invade into bladder tissue was assed as 1, 3, and 6 hr post infection. Intracellular bacteria were able to invade into the bladder tissue while extracellular bacteria were detected in the bladder lumen. Abbreviations. B = bladder, K = kidney, CI = competitive index. Bars represent mean (**A--E**), geometric mean (**F, H**), and median (**G**). \*p\<0.05, \*\*p\<0.01, \*\*\*p\<0.001, \*\*\*\*p\<0.0001 by Wilcoxon Signed Ranked test (**A--F**) or Mann Whitney U test (**G, H**). N = 10, 2 replicates (**A, G, H**); N = 11, 2 replicates (**B, E**); N = 16, 3 replictates (**C**); N = 18, 3 replicates (**D**); N = 20 mice, 4 replicates (**F, G**); N = 15, 3 replicates, (**H**); N = 4, 2 replicates (**I**). All replicates are biological.](elife-31662-fig5){#fig5}

In mice infected with a single UTI89 strain, the WT and P132R variant caused chronic cystitis at similar rates (45% and 30%, respectively) ([Figure 5F](#fig5){ref-type="fig"}, [Figure 5---figure supplement 3](#fig5s3){ref-type="fig"}). However, the D114R and D62R mutant strains had reduced rates of chronic cystitis of 20% and 10%, respectively. Interestingly, 100% of mice infected with the A22R variant resolved their infections over the 4 week experiment, with half of the mice (10/20) exhibiting sterile urines by 10 dpi compared to just 15% (3/20) of mice infected with the WT strain at the same time point ([Figure 5---figure supplement 3](#fig5s3){ref-type="fig"}). The defect in chronic infection caused by *fimA* variants is likely due to pathogenic deficiencies during acute UTI. Accordingly, we found that two *fimA* variants (A22R and D114R) significantly altered the ability of UTI89 to form IBCs at 6 hr post infection (hpi) ([Figure 5G](#fig5){ref-type="fig"}), with 8/10 mice infected with the D114R variant forming \<15 IBCs. Even more strikingly, 70% of mice infected with the A22R variant formed no IBCs at 6 hpi and the other 30% formed three or less. This is in stark contrast to WT and P132R strains, which formed between 50--100 IBCs on average by 6hpi. Interestingly, the A22R mutant was severely attenuated in its ability to invade into bladder cells starting as early as 1 hr post infection ([Figure 5H](#fig5){ref-type="fig"}). The D62R variant was defective in chronic cystitis in both the competitive and single bladder infections, but no acute fitness defects were observed. Further, mice infected with D62R formed a similar number of IBCs as the WT strain at 6 hpi, suggesting that the defect occurs at a later time-point. Accordingly, in mice singly infected with *fimA* D62R bacterial clearance is delayed, starting between 10--14 days ([Figure 5---figure supplement 3](#fig5s3){ref-type="fig"}).

In addition to playing a pivotal role in the urinary tract, a recent study found that type 1 pili also promote the establishment and/or maintenance of the UPEC intestinal reservoir ([@bib68]). Deletion of the operon encoding the type 1 pilus or the FimH adhesin impedes intestinal colonization by UTI89 ([@bib68]). Therefore, we tested the impact of each of our four chromosomal FimA genetic variants on UPEC intestinal colonization levels. We found that strains producing FimA~UTI89~ variants D62R, D114R, and A22R showed lower levels of intestinal colonization (by up to 2 logs) in the feces, cecum, and colon of mice compared to those colonized by WT *fimA *([Figure 6](#fig6){ref-type="fig"}). This 2-log decrease mirrors the defect observed in UTI89Δ*fim* or UTI89Δ*fimH* strains, suggesting that these mutations prevent type 1 pilus-dependent gut colonization in UTI89 ([@bib68]). While not statistically significant, *fimA~UTI89~* P132R variant showed lower colonization (by up to one log) in the feces and cecum than the WT strain ([Figure 6](#fig6){ref-type="fig"}). Together, our data indicates that the sequence of the FimA major subunit is critical for pilus function in the bladder and gut and thus has a major impact on the outcome of UTI.

![Mutations in FimA alter the ability of UTI89 to colonize the intestine.\
C3H/HeN mice were orally gavaged with streptomycin, to disrupt colonization resistance, and one day later orally gavaged with 1 × 10^8^ CFU of WT UTI89 or one of 4 isogenic UTI89 strains with point mutations in *fimA*. The burden of each FimA mutant was determined via CFU counting in were determined the feces, cecum, or colon of mice at 7 days post colonization. Bars represent geometric mean. \*p\<0.05, \*\*p\<0.01, \*\*\*p\<0.001, \*\*\*\*p\<0.0001 by Mann Whitney U test. N = 10, 2 biological replicates.](elife-31662-fig6){#fig6}

Discussion {#s3}
==========

The power of Cryo-EM to define the structure of helical polymers {#s3-1}
----------------------------------------------------------------

Tremendous advances in cryo-EM within the past four years ([@bib22]; [@bib71]) largely driven by the introduction of direct electron detectors ([@bib50]) has meant that many complexes that were recalcitrant to crystallization can now be readily solved at near-atomic resolution by cryo-EM. In particular, it is exceedingly difficult to crystallize most helical polymers, as unless such a polymer has exactly two, three, four or six subunits per turn, it cannot be packed in any crystal space group so that all subunits are in equivalent environments. The type 1 pilin, FimA, has been extensively studied by x-ray crystallography and solution NMR, while the type 1 pilus has only been studied at high resolution by solid-state NMR ([@bib31]). We show here that type 1 filaments, present as a background in a preparation of T4P, allow us to reach a near-atomic level of resolution and build an atomic model for the FimA rod. The ability of cryo-EM to separate out multiple conformations among particles ([@bib30]; [@bib76]) or even of subunits within the same particle ([@bib60]) has been one of the greatest strengths of cryo-EM, allowing for multiple states to be solved from the same micrographs. Biochemically heterogeneous preparations, such as when virions are a mixture of empty particles and those containing DNA ([@bib19]) are now routinely sorted out into homogeneous structural classes. We have taken advantage of that strength here to show that filament images which might otherwise have been discarded as a background contaminant can actually be used to build an atomic model. Our type 1 pilus rod model provides new insights into structure-function relationships in type 1 pili.

Residues responsible for the structure of FimA influences UPEC colonization of the bladder and gut {#s3-2}
--------------------------------------------------------------------------------------------------

FimA is critical for proper assembly of the type 1 pilus and, as the major subunit that makes up the pilus rod, is also critical for the proper display of the FimH adhesin. However, here we have uncovered a more complex and previously unappreciated role for FimA and the type 1 pilus rod in host-pathogen interactions. We identified three mutations in FimA~UTI89~ (A22R, D114R, and D62R) that expressed adhesive pili in vitro but reduced the ability of UTI89 to colonize the bladder, acutely and chronically. One of these mutants, FimA~UTI89~ A22R, was severely attenuated during acute infection, forming almost no IBCs and thus was unable to chronically infect the mouse bladder.

The impact of FimA mutants on the 'molecular-spring' function of the pilus rod {#s3-3}
------------------------------------------------------------------------------

We hypothesize that the identified FimA point mutants handicap UPEC pathogenicity in vivo by altering the properties of the pilus rod. The pilus rod is hypothesized to act as a 'molecular spring' transitioning between a flexible, linear fiber and a coiled helix. This spring-like property is thought to prevent the pilus from breaking or detaching from the host surface by temporarily expanding to a linear form after encountering shear forces, which can occur in the bladder during urine voiding or in the gut during fecal or mucus shedding. Such a transition between the helical and unwound form of the FimA homopolymer has been predicted to significantly dampen the force experienced by the adhesion-receptor complex at the tip ([@bib83]). Since FimA-FimA interactions create the bulk of the pilus rod, mutations that reduce the stability of these protein-protein interactions can alter the ability of the pilus rod to withstand shear forces, which we discovered has detrimental effects on pilus function and pathogenesis. This is consistent with \~50% of the residues in the mature FimA protein (79/161) being invariant ([Figure 3](#fig3){ref-type="fig"}), which includes almost every residue involved in a subunit-subunit interface in the rod. Pili formed with the WT FimA~BW25113~ protein require more than twice the force to unwind than the pili formed by the FimA ~BW25113~ variant with an A22R mutation (\~30 pN vs. 11pN), likely due to steric clashes caused by this substitution affecting the tightly packed interface between subunits. Thus, we hypothesize that the pilus formed by the FimA A22R mutant variant may not have the strength to absorb and withstand the shear forces experienced during urination and thus allow the bacteria to be swept out of the bladder, preventing infection. In the gut, the pilus rod may play a similar role during mucus shedding. A recent study suggests that type 1 pili may promote UPEC colonization of the upper crypts ([@bib68]). These bacteria would likely experience constant, low levels of shear force during mucus turnover and thus need the pilus to withstand some force to enable the bacteria to maintain their intestinal niche. Accordingly, three of the *fimA~UTI89~* mutants (A22R, D114R, and D62R) that were attenuated in bladder colonization also displayed significantly reduced intestinal colonization. However, in general, the phenotypes of the *fimA~UTI89~* mutants in gut colonization were not as severe as in the bladder.

Two mutations in FimA~UTI89~ (D62R and D114R) resulted in a mild clumping phenotype when bacteria were grown in vitro. This clumping phenotype was also seen in the equivalent mutants in FimA~BW25113~ (D62R, D114R). These residues are located on the exterior surface of the rod structure and do not have as strong an effect on the force needed for unwinding as FimA~BW2511~ A22R. However, the clumping phenotype suggests that these mutations may alter side-to-side interactions between different pilus rods promoting pilus-pilus interactions within and between bacteria, thus inhibiting the pilus mediated interactions needed in vivo for attachment, invasion and/or IBC formation. Interestingly, we do not observe a defect in bladder colonization in mice infected with FimA~UTI89~ D62R until 10dpi, suggesting that normal rod function is needed during both chronic and acute infection.

Together, our data suggest that the type 1 pilus rod may mediate colonization phenotypes through damping of shear forces or through other mechanism(s) outside of scaffold support for FimH-binding. A possibility that we cannot exclude at the moment is that the lower uncoiling force of the A22R mutant exposes parts of the rod that would be largely buried in the wt filament to host proteases. This would still suggest that the mechanical properties of these rods have been 'tuned' to optimize for particular environments, as a wt rod that could never uncoil would be susceptible to breakage by the shear forces, while a rod that uncoils too easily would be unnecessarily exposed to digestion by proteases.

Our analyses indicate that FimA is undergoing selection pressures due to as-yet undefined host-pathogen interactions, which may explain some colonization defects seen here. FimA displays patterns of episodic, divergent selection on surface exposed amino acids in a pattern that is similar, though much less robust, to what is seen in the flagellin protein in *Salmonella* ([@bib49]). In *Salmonella*, the flagellin subunits are split into several domains where the domains responsible for subunit-subunit assembly are highly conserved while the more external domains of the protein show high rates of variability ([@bib4]; [@bib28]). The *Salmonella* flagellin protein is immunogenic, but the regions that induce inflammatory response are found in the conserved domains of the protein ([@bib79]). While it is known that flagellin are bound by Toll-like receptor 5 (TLR5) resulting in the induction of the innate immune response ([@bib66]) and that this recognition is targeted towards conserved features of flagellin ([@bib4]), it is currently unknown which, if any, host immune receptor are capable of recognizing the FimA rod or subunits or which structural features are targeted by the host immune system. Further research is needed to fully elucidate the host pressures and responses that are influencing the evolution of the FimA rod structure.

The evolution of the type 1 pilus rod {#s3-4}
-------------------------------------

Evolutionary and structural analysis of FimA, in combination with our in vitro and in vivo phenotyping, yielded several important insights into the selection pressures faced by UPEC as well as the evolutionary trajectories that pathogens follow to enhance their colonization of different host niches. Notably, we saw that different phenotypes caused by mutations in the FimA protein were associated with different classes of selection pressure. For example, the bacterial clumping phenotype is associated with mutation of three codons under purifying selection, but an equal number of the mutations that resulted in clumping are in codons with little to no evidence of selective pressure. In contrast, all mutations that failed to complement a *fimA* gene deletion were made in codons that are under very strong purifying selection or are too conserved for analysis. Together, the difference in selection pressure suggests that the mis-assembly of the pilus is much more harmful and/or toxic to *E. coli* than bacterial clumping. Further, the integration of evolutionary analysis with in vivo and in vitro functional analysis allowed us to decouple the selection pressures acting to preserve amino acid sites necessary for pilus assembly (such as P145in FimA~UTI89~) from the selection pressure maintaining the codons that were necessary for pilus function (such as A22 in FimA~UTI89~). Given the intricacy of pilus assembly, one could expect that most of the codons under purifying selection would be related to pilus construction. Instead, we found that many codons under purifying selection are involved in keeping the force needed to unwind the type 1 rod within a narrow range. This leads to reasoning that a 'weak' or 'loose' FimA rod may be just as detrimental for *E. coli* as having no rod at all, at least in the eyes of evolution.

In summary, by combining structural studies, force spectroscopy, genetic analysis, and relevant mouse models of UTI and gut colonization, we conclude that the mechanical properties of the type 1 pilus rod are essential for its functional role in mediating *E. coli* pathogenesis and persistence and appear to have been carefully 'tuned' by evolution. Further studies of the hundreds of CUP pili encoded in Gram-negative bacteria are needed to further understand the unique and general aspects of the evolution of CUP pilus fibers. In addition, other bacterial pili, such as T4P, which have arisen independently of CUP pili but can play similar roles in pathogenesis, can also elongate under force ([@bib11]) and thus it remains an interesting question as to how the physical properties of other pili have been selected for particular environments and how these properties impact bacterial pathogenesis.

Materials and methods {#s4}
=====================

Ethics statement {#s4-1}
----------------

The Washington University Animal Studies Committee approved all procedures used for the mouse experiments described in the present study. Overall care of the animals was consistent with *The Guide for the Care and Use of Laboratory Animals* from the National Research Council and the USDA *Animal Care Resource Guide*.

Bacteria, cloning, mutagenesis {#s4-2}
------------------------------

The BW25113 *fimA* gene sequence was cloned between the *EcoRI* and *BamHI* restriction sites in pTRC99A using standard PCR cloning techniques to create plasmid pTRC-fimA. Mutations were made within this plasmid using appropriate complementary primers to engineer codon changes in the template, pTRC-fimA, using *Pfx* polymerase and manufacturers instructions for PCR, followed by *DpnI* treatment of the resulting products to remove the methylated template before transformation into C600. Mutations were verified by sequencing. Mutant plasmids were transformed into UTI89-LON*, ∆fimA* for expression and functional studies as indicated.

In order to construct point mutations in the *fimA* allele in the UTI89 chromosome, the UTI89 *fimA* gene was deleted using a previously published technique that allows for flawless integration ([@bib43]). Briefly, *fimA* was deleted by homologous recombination using pSLC- 217 as a template and primers containing 50 bp of homology to flanking regions of *fimA*. A deletion was then constructed using the previously described Red Recombinase method that would allow for reinsertion of constructs into the *fimA* site. Concurrently, a copy of UTI89 *fimA* was cloned into pTRC99a. Point mutations were then introduced into this construct using site directed mutagenesis. PCR fragments from confirmed mutants, and the WT allele, were reintegrated into the UTI89-LON, ∆*fimA* mutants constructed above at the original deletion site. Successful reintegration events were sequenced to confirm flawless integration and mutation presence.

Mouse studies {#s4-3}
-------------

Animals were maintained in a single room in our vivarium. Prior to and after infection all animals received PicoLab Rodent Diet 20 (Purina) *ad libitum*. All animals were maintained under a strict light cycle (lights on at 0600 hr, off at 1800 hr). Mice were acquired from indicated vendors and randomly placed into cages (n = 5 mice/cage) by employees of Washington University's Division of Comparative Medicine (DCM); no additional methods for randomization were used to determine how animals were allocated to experimental groups. Investigators were not blinded to group allocation during experiments.

For bladder infections, 6 week old female C3H/HeN mice were obtained from Envigo and were maintained in our vivarium for one week prior to infection. Bladder infections were performed via transurethral inoculation ([@bib35]). UPEC strains were prepared for inoculation as described previously ([@bib35]). Briefly, a single UTI89 colony was inoculated in 20 mL of Luria Broth (LB) and incubated at 37°C under static conditions for 24 hr. Bacteria were then diluted (1:1000) into fresh LB and incubated at 37°C under static conditions for 18--24 hr. Bacteria were subsequently washed three times with PBS and then concentrated to \~1×10^8^ CFU per 100 μL for intestinal infections and \~1×10^8^ CFU per 50 μL for bladder infections. Bacteria were subsequently washed three times with PBS and then concentrated to \~1×10^8^ CFU per 50 μL for bladder infections.

For intestinal colonization experiments, 6 week old female C3H/HeN mice were obtained from Envigo and were maintained in our vivarium for no more than 2 days prior to intestinal colonization. Mice received a single dose of streptomycin (1000 mg/kg in 100 μL water by oral gavage (PO)) followed 24 hr later by an oral gavage of ∼10^8^ CFU UPEC in 100 μL phosphate-buffered saline (PBS) ([@bib68]). Bacteria were subsequently washed three times with PBS and then concentrated to \~1×10^8^ CFU per 100 μL for intestinal infections.

In all cases, fecal and urine samples were collected directly from each animal at the indicated time points. Fecal samples were immediately weighed and homogenized in 1 mL PBS. Urine samples were immediately diluted 1:10 prior to plating. Mice were sacrificed via cervical dislocation under isofluorane anesthesia and their organs were removed and processed under aseptic conditions. Intestinal segments (cecum and colon) were weighed prior to homogenization and plating on LB supplemented with the appropriate antibiotic.

Exclusion criteria for mice were pre-established; (i) both introduced strains in competitive infections became undetectable during the course of a 14 day experiment, and (ii) mice died or lost \>20% of their body weight. No mice in this study met these criteria. Each experiment was conducted with both technical (i.e., a single inoculum of bacteria) and biological (i.e., separate bacterial cultures of the same strain) replicates.

Enumeration of intracellular bacteria {#s4-4}
-------------------------------------

6 week old female C3H/HeN mice were given a transurethral inoculation with WT UTI89 or a *fimA* mutant strain. To accurately count the number of IBCs, mice were sacrificed 6 or 12 hr after infection. Bladders were removed aseptically, bi-sected, splayed on silicone plates and fixed in 4% (v/v) paraformaldehyde. IBCs, readily discernable as punctate violet spots, were quantified by LacZ staining of bladder wholemounts ([@bib39]; [@bib15]). Bacterial invasion assays were performed at 1, 3, and 6 hr post infection as previously described ([@bib55]).

Hemagglutination assays (HA) {#s4-5}
----------------------------

Bacteria were grown under type 1 pilus-inducing conditions ([@bib29]), with appropriate antibiotics and. 01-.02mM IPTG induction, if indicated. Pilus expression was assessed by hemagglutination assays (HA) as previously described ([@bib29]) using bacterial cultures normalized to an optical density at 600 nm (OD~600~) of 1 and guinea pig erythrocytes normalized to an OD~640~ of 2. The experiment was conducted in parallel in PBS with 2% w/v methyl-α-D-mannopyranoside.

Electron microscopy {#s4-6}
-------------------

Electron micrographs (EM) were taken of UTI89 or UTI89 isogenic mutants after growth under type 1 pilus-inducing conditions. A total of 300 bacterial cells were counted for each condition, and piliation on those cells was classified as bald (no pili), low (1 to 20 pili/cell), moderate (20 to 200 pili/cell), or abundant (\>200 pili/cell).

Force extension experiments {#s4-7}
---------------------------

For expression of type 1 pili the strains were grown in Luria Broth (LB) supplemented with carbenicillin (100 µg/mL) and IPTG (50 µM), at 37°C overnight. The optical tweezers (OT) setup is built around an inverted microscope (Olympus IX71, Olympus, Japan) equipped with a high numerical aperture oil immersion objective (model: UplanFl 100X N.A. = 1.35; Olympus, Japan) and a 1292 × 964 pixel camera with a cell size of 3.75 × 3.75 μm (model: StingRay F-125, Allied Vision) ([@bib54])([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). The OT stands in a temperature controlled room with computers and controllers isolated from the room to reduce noise and vibrations. We use a continuous wave Nd:YVO~4~ laser (Millennia IR, Spectra Physics, Santa Clara, CA) operating at 1064 nm for trapping a single bacterium or microspheres. A probe laser (low power HeNe-laser operating at 632.8 nm) is merged with the trapping laser using a polarizing beam splitter cube (PBSC). The light from the probe laser is refracted by the trapped object and collected by the condenser and thereafter imaged onto a 2D position sensitive detector (PSD, L20 SU9, Sitek Electro Optics, Sweden). The PSD convert the incoming light to a photocurrent and thereafter to a voltage that is sent to a programmable low pass filter (SR640, Stanford research systems), later collected by a computer and processed with an in-house LabVIEW program. We minimized the amount of noise in the setup and optimized the measured time series using the Allan variance method described in ([@bib6]).

To prepare a sample we suspended bacteria in 1xPBS to a concentration (1:1000 of OD~600~ = 1) suitable for single cell analysis using optical tweezers (OT). Surfactant-free 2.5 µm amidine polystyrene microspheres (product no. 3--2600, Invitrogen, Carlsbad, CA) were similarly suspended in Milli-Q water, these microspheres were trapped and used as force probes. To mount bacteria and reduce the influence of surface interactions we prepared a 1:500 suspension of 9.5 mm carboxylate-modified latex microspheres (product no.2--10000, Interfacial Dynamics, Portland, OR) in Milli-Q. We dropped ten microliters of the microsphere-water suspension onto 24 × 60 mm coverslips (no.1, Knittel Glass, Braunschweig, Germany) and placed these in an oven for 60 min at 60°C to immobilize the microspheres to the surface. To firmly adhere bacteria to the microspheres, we added a solution of 20 mL of 0.01% poly-L-lysine (catalog no. P4832, Sigma-Aldrich, St. Louis, MO) to the coverslips, which, after 45 min incubation at 60°C, were stored until use. A free-floating bacterium was trapped by the optical tweezers run at low power to avoid cell damage. The bacterium was thereafter mounted on a large 9.5 µm microsphere coated with poly-L-lysine. We trapped a small free-floating 2.5 µm microsphere by the optical tweezers with normal power (a few hundreds of mW) and brought it close to (within tens of µm) but not in direct contact with, the bacterium. To calibrate the trap stiffness we used the Power spectrum method by sampling the microspheres position at 131,072 Hz and average 32 consecutive data sets acquired for 0.25 s each ([@bib75]). Typically, the trap constant was found to be \~140 pN/µm for an output laser power of 800 mW. After calibration, the small microsphere was gently brought close to the bacterium in order to attach a pilus with the microsphere ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). To extend a single pilus ([Figure 4](#fig4){ref-type="fig"}) the piezo stage was moved at a constant speed of 10 nm/s and the sampling frequency was set to 10,000 Hz that was downsampled by 800. Occasionally, we measured the responses of multiple pili attached to the bead resulting in a force-extension response as the sum of all attached pili. This was, however, not a problem in general since the shorter pili detached from the bead in a sequential order, leaving only the single, longest pili attached to the bead for measurement ([Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}). Finally, we controlled the piezo-stage and sampled the data using an in-house LabView program ([@bib8]; copy archived at <https://github.com/elifesciences-publications/ot-control>).

To make a flow chamber, we added a ring of vacuum grease (Dow Corning, Midland, MI) around the area containing the poly-L-lysine-coated microspheres on one of the coverslips. Carefully, we dropped a 3 mL suspension of bacteria and a 3 mL suspension of probe microspheres (surfactant-free 2.5 mm white amidine polystyrene latex microsphere, product no. 3--2600, Invitrogen, Carlsbad, CA) onto the area and sealed the flow chamber by placing a 20 × 20 mm coverslip (no.1, Knittel Glass) on top. Thereafter, we mounted the sample in a sample holder that is fixed to a piezo-stage (Physik Instrument, P-561.3CD stage) in the OT instrumentation. To get a reliable OT calibration parameter values we measured the temperature using a thermocouple in the sample chamber, 23.0 ± 0.1°C and the suspension viscosity was assumed to only vary with temperature, thus, the viscosity was set to 0.932 mPas ± 0.002 mPas.

Pilus preparation for structural determination {#s4-8}
----------------------------------------------

To prepare the pilus extracts, bacteria of the *E. coli* strain BW25113 ([@bib16]) were inoculated by dense streaking on eight M9 minimal agar plates containing 0.5% glycerol (vol/vol). After a 72 hr incubation at 30°C, bacteria were harvested in 30 mL of LB medium, vortexed vigorously for 5 min and passed eight times through a 26-Gauge needle, to detach pili from the cells. Bacteria were removed at 4°C by three successive 10 min centrifugation steps at 16,000 x g. To collect the pili, cleared supernatants were centrifuged for 1 hr at 100,000 *g* in a cold Beckman Ti60 ultracentrifuge rotor. Pellet containing the crude pilus fraction was taken up in 200 μL of 50 mM HEPES, 50 mM NaCl pH 7.4, and maintained at 4°C for further analysis.

Cryo-EM data collection and image processing {#s4-9}
--------------------------------------------

3 μL of sample was applied to glow discharged lacey carbon grids (TED PELLA, Inc., 300 mesh). Then the grids were plunge-frozen using a Vitrobot Mark IV (FEI, Inc.), and subsequently imaged in a Titan Krios at 300keV with a Falcon II direct electron detector (pixel size 1.05 Å/pixel). A total of 6803 images, each of which was from a total exposure of 2 s dose-fractionated into seven chunks, were collected at a range of underfocus between 0.5 \~ 3 μm. Images were motion corrected using MotionCorr ([@bib50]), and the program CTFFIND3 ([@bib53]) was used for determining the defocus and astigmatism. Images with poor CTF estimation as well as defocus \>3 μm were discarded. The SPIDER software package ([@bib27]) was used for most other operations with the first two-chunk sums (containing a dose of \~20 electrons/ Å^2^) of the motion-corrected image stacks. The CTF was corrected by multiplying the images from the first two-chunk sums with the theoretical CTF, which is a Wiener filter in the limit of a very poor signal-to-noise ratio (SNR). This both corrects the phases which need to be flipped and improves the SNR. The e2helixboxer routine within EMAN2 ([@bib72]) was used for boxing the filaments from the images. A total of 72,627 overlapping segments (384 px long), with a shift of 11 px between adjacent segments (\~97% overlap), were used for the IHRSR ([@bib21]) reconstruction. With a featureless cylinder as a starting reference, 72,627 segments were used in IHRSR cycles until the helical parameters (axial rise and rotation per subunit) converged. Analysis of the population suggested that the axial rise was fairly fixed, but that the twist was variable. Using a reference-based sorting with models having a fixed rise but a variable twist, approximately 55% of the segments were excluded, having a twist outside of the range 114.4° to 115.6°. A sub-set of 32,726 segments were used for a few more cycles of IHRSR. The resolution of the final reconstruction was determined by the FSC between two independent half maps, generated from two non-overlapping data sets, which was 4.2 Å at FSC = 0.143.

Model building and refinement {#s4-10}
-----------------------------

We used a previous FimA NMR model (PDB id: 2JTY, a single chain) as an initial template to dock into the cryo-EM map by rigid body fitting, and then manually edited the model in Chimera ([@bib57]) and Coot ([@bib23]). We then used the combined model (1--19 and 21--159) as the starting template to re-build a single chain of the FimA protein using the RosettaCM protocol ([@bib78]). Next, the full length model of FimA missing the first two residues and the last residue was iteratively refined by Phenix real-space refine ([@bib2]) and manually adjusted in Coot. The refined single chain of the FimA model was then re-built by RosettaCM ([@bib78]) with helical symmetry and refined by Phenix to improve the stereochemistry as well as the model map coefficient correlation. The FimA model was validated with MolProbity ([@bib13]) and the coordinates deposited to the Protein Data Bank with the accession code 6C53 (atomic structure). The corresponding cryo-EM map was deposited in the EMDB with accession code EMD-7342. The refinement statistics are given in [Supplementary file 1](#supp1){ref-type="supplementary-material"}.

Bioinformatic analyses {#s4-11}
----------------------

The protein sequences of closely-related homologs of *E. coli* FimA, FimC, and FimH were obtained by individual searches the Ensembl Bacteria Genome database ([@bib42]) using the phmmer web-server ([@bib25]) with a BLOSUM62 (FimA) or a BLOSUM90 (FimC and FimH) scoring matrix using the full-length *E. coli* UTI89 protein sequences as queries. The sequence matches were then filtered to remove low scoring hits and non-functional sequences (i.e., those predicted to lack critical sequence features such as complete signal sequences and/or C-terminal tyrosine residues in FimA and FimH). The signal sequences were trimmed from the remaining homologs using Geneious v 6.1.7 ([@bib41]) and the protein sequences were aligned with the MAFFT program using two iterations of the FFT-NS-i algorithm based on the PAM200 scoring matrix ([@bib40]). Conservation at each amino acid position was calculated using custom Python scripts and a sequence logo was created using the ggseqlogo package in R ([@bib59]) using RStudio ([@bib73]).

To estimate selection pressures on each codon in *fimA*, we obtained all available gene sequences encoding the protein sequences described above from the Ensembl Bacteria Genomes database (n = 1,825, three were removed by submitter's request) using custom bash scripts ([Supplementary file 3](#supp3){ref-type="supplementary-material"}). A total of 191 unique sequences were identified using Geneious v 6.1.7 and trimmed to remove the signal sequence. Evolutionary model selection was performed using maximum likelihood ratio testing on the Datamonkey webserver ([@bib58]; [@bib17]), which identified the TIM2 model (model 010232) as the most likely model of nucleotide substitution for the *fimA* homologs. These sequences were then were scanned for evidence of recombination using single breakpoint analysis ([@bib46]) and phylogenetic trees with a correction for a breakpoint found in codon 107 (position 320) were generated. These phylogenetic trees and evolutionary model were then used to measure the ratio of the rates non-synonymous (*dN*) to synonymous (*dS*) mutation in each codon (i.e., a *dN*/*dS* ratio) using a fixed-effects likelihood test to identify statistical significance ([@bib44]).

Using a collection of 67 curated, reference genomes from a previous study ([@bib65]), we examined the carriage and phylogenetic context of *fimA* carriage using a BLAST-based search ([@bib12]) with the UTI89 *fimA* gene as a query. Full-length sequences were extracted from the genomes using Geneious v 6.1.7, trimmed to remove signal sequences, and aligned using the MUSCLE program ([@bib20]). A phylogenetic tree was estimated using the RAxML program ([@bib70]) with the GTRCAT model and supported with 1000 bootstraps ([@bib69]). Evidence for episodic, diversifying selection was then identified using a random effects likelihood ratio test for each branch of the *fimA* phylogenetic tree ([@bib45]) using unique sequences from the genomes (32 duplicates removed, n = 25). Branches showing statistically significant evidence for episodic, diversifying selection, as measured by a chi-squared test were then indicated on the corresponding branches of the phylogenetic tree constructed using RAxML.
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Reviewing Editor
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"Functional role of the type 1 pilus rod structure in mediating host-pathogen interactions\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, including Michael Gilmore as Reviewing Editor, and the evaluation has been overseen by Gisela Storz as the Senior Editor.

We have drafted this decision to help you prepare a revised submission.

Summary:

This is a well-written structural biology study that employs state-of-the art cryo EM to solve the structure of the assembled type 1 pilus rod of *E. coli*. This pilus is a major colonization factor for *E. coli* and other gram-negative microbes, in the gut and in the bladder, with a well-established role in urinary tract infection. Prior to this study, substantial knowledge of the type 1 pilus structure derived from multiple approaches to solve the structure of the FimA monomer, and NMR data on polymerized FimA. The data obtained here extends and modifies the understanding of its structure in several specific aspects. Moreover, force measurements of mutant variants of the pilus are consistent with a model that proposes that specific extension forces are functionally important, and the tension of its spring-like quality is critical for causing disease. Additionally, useful insights are made into the evolution of variants of this structure, and selective forces that may influence that. All of the elements of the study appear to be well designed and executed, and reflect both a deep understanding of the subject of study, and advanced technologies for its exploration.

Essential revisions:

There are two major points to be addressed:

1\) Determination of unwinding force and correlation between unwinding force and in vivo observations are not convincing yet and need to be substantiated.

2\) When correlating the in vitro and in vivo results, there are several uncontrolled variables that need to be addressed including proteases, bacterial clumping, number of pili versus structure of pili for fimA mutants.

Further detail can be found in the separate reviews below. If you have any questions about the revisions, please let us know.

*Reviewer \#1:*

The only concern of this reviewer is that some leaps are made to correlate observations in vitro, with those in vivo. The suggestion that the spring-like qualities of the pilus rod are critical for pathogenesis is entirely possible, but is far from proven. Moreover, few specifics are provided that relate the actual shear forces of urine at various distances from the mucosal boundary to the forces measured for variations in the protein. A number of uncontrolled variables could explain why mutant variants of the protein are less effective in vivo, including increased susceptibility to tissue resident proteases, altered interactions with various elements of the mucosa, altered physical states imposed (such as the clumping that was observed), etc. While an interesting prospect, the mechanical properties proposed could be explored further for proof, or the discussion of this prospect modified in the text (although the latter arguably could affect the perceived impact of the study in altering existing paradigms). Aside from that concern, this reviewer found the paper to be of considerable interest and well done.

*Reviewer \#2:*

The authors determined the Type I pilus structure by cryo electron microscopy. The images in [Figure 1](#fig1){ref-type="fig"} are stunning. The determine force required to unwind a single FimA rod, and then introduce mutations that would be predicted to destabilize the wound pilus structure. These mutant pili require less force to unwind. Interestingly, UPEC expressing these mutant pili were significantly attenuated in bladder infection and intestinal colonization in mice, despite being able to agglutinate red blood cells in vitro. The authors have not identified the specific host immune response which contribute to pathogenic deficiencies, but clearly the sequence of the FimA major subunit are critical for pilus function in the bladder and gut and thus has a major impact on the outcome of UTI. Below are some comments and suggestions that could be addressed in a revised manuscript.

1\) The A22R mutant has a significant defect at 6 hours in the mouse. Does this mutant affect the ability of bacteria to invade the superficial facet cells?

2\) A few of the mutants were tested in vivo, but not in vitro. For example, E123R was tested in the mouse and displayed a defect in acute and chronic UTI (and a slight defect in gut colonization), but the force measurements for unwinding this pili were not determined.

*Reviewer \#3:*

The manuscript by Caitlin Spaulding et al. reports on the relation between atomic structure, evolutionary conservation, biophysical properties, and host pathogen interactions of bacterial type I pili. Using electron microscopy, they solve the structure of the type I pilus at atomic resolution. Next, by genomic comparison of the T1P genes between different species, they find that the gene encoding of the major subunit of the pilus, fimA, shows a higher variability compared to other parts of the T1P machinery. In particular, residues at the exterior are prone to adaptive selection. Based on their positions in the atomic model, the authors investigate the effects of point mutations on pilus expression and agglutination. They state that the unwinding force of the pilus strongly depends on these mutations while functionality is unaffected. Finally, they investigate the effect of point mutations on the competitive fitness within the bladder of a mouse model, on their ability cause chronic infections, and on their ability to colonize the intestine. The authors conclude that reducing the unwinding force of T1P affects host-pathogen interactions.

The idea to test the relevance of elastic properties of pili for host-pathogen interactions and in particular of bladder infections is wonderful. The general approach of starting with an atomic model of the pilus to identify promising candidates for amino acid substitutions is highly convincing. I have three major problems with this study and I will describe them in detail below. I would like to state that I don\'t have enough expertise in structural biology to assess the quality of the structural data.

1\) Measurement of the unwinding force.a) The authors state in the Materials and methods part they expect \"attachment a few pili with the microsphere\". Determination of the unwinding force, however, is only possible it the authors can make sure that only a single pilus is attached at the time.

b\) I haven\'t found any information about how the mutations analysed in [Figure 4B](#fig4){ref-type="fig"} affect the number of pili per cell. If more than a pilus is bound during a force measurement, then the level of piliation can affect the measured uncoiling force.

c\) Only technical replicates from a single sample are inacceptable. Data should be acquired on biological replicates on at least three different days.

2\) Expression levels and functionality of pili with point mutations.

The authors state that \"FimA mutant strain produced minimal changes to the levels of type 1 piliation \[...\] and to the function of the type 1 pilus\". The experimental data supporting this statement is shown in [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}. I cannot understand this statement based on the data. The percentage of \"bald\" bacteria is about 3x higher for the D116R strain compared to wt. The mannose-inhibitable HA-titre is about 10x higher in the E123R and D116R strains compared to wt. We can expect that the pilus density affects host-pathogen interactions. One way of showing that the 3x increase of pilus density does not affect the conclusion, would be to generate strains with wt fimA sequence but decreased pilus levels.

3\) Comparison between different strains.a) The authors explain that they used different bacterial strains with different fimA sequences. This is probably fine, but the way the data is presented now, I get confused with the different notations of the point mutations. For example, is the A22R mutation in [Figure 4B](#fig4){ref-type="fig"} comparable to A24R in [Figure 5G](#fig5){ref-type="fig"}? Same for D114R and D116R etc.? Can the authors come up with a smart way of indicating these connections within the figures?

b\) The authors look at the effects of amino acid substitutions at different levels of complexity (which is great) but I currently get lost in the details. Please explain the criteria for analysing specific mutations better within the individual parts of the Results section. Also, please explain the connections between the conclusions drawn from mutant analysis of conservation, unwinding, and host-pathogen interactions related to the structure in an explicit way.

10.7554/eLife.31662.031

Author response

> Essential revisions:
>
> There are two major points to be addressed:
>
> 1\) Determination of unwinding force and correlation between unwinding force and in vivo observations are not convincing yet and need to be substantiated.

We thank the reviewers for bringing up this point. Determination of the unwinding force of the WT type 1 pili in this study correlates well with previously published studies (Andersson et al., 2007; Jass et al., 2004; Whitfield et al., 2014). There have been numerous parallel-plate flow chamber studies mimicking the fluid conditions exposing bacteria attaching to host cells. These studies show indeed the need of pili for cell attachment (works by Wendy Thomas group). In such in vitro studies, it has been observed that pili do in fact unwind when the cell is exposed to fluid flow (Rangel et al., 2013).

Correspondingly, in this study we find that the unwinding force is significantly different for the WT and the A22R mutant and this mutant is severely attenuated in bladder and gut colonization.

> 2\) When correlating the in vitro and in vivo results, there are several uncontrolled variables that need to be addressed including proteases, bacterial clumping, number of pili versus structure of pili for fimA mutants.

The reviewers are correct in pointing out that there are uncontrolled variables in our in vitro and in vivo experiments. in vitro bacterial clumping and pilus expression are variable between FimA mutants, however, we show via hemagglutination assays that this does not impact the function of these pili in vitro. We do find differences between WT and mutant FimA expressing strains in both two different niches within the urinary tract (the bladder and the kidney) and within the gut. In allin vivo mouse experiments, there are numerous uncontrolled variables present, including host and bacterial proteases. While we do not control for these proteins in our studies, we note that we use the same strain of mice for each experiment and biological replicates for experiments are performed in mice that are the same age, from the same vendor and batch, and have been exposed to the same conditions and diet in our vivarium. While host proteases might alter pathogenesis, our WT and mutant mice should be exposed to the same protease conditions. We have now added the possibility to the Discussion that the uncoiling of the A22R mutant might make sites accessible to host proteases that would not be available in the coiled wt rod. As we note, this does not change the conclusion of our paper that the mechanical properties of the rod have been "tuned" over evolution as an adaptation to specific environments. Further, while we feel that the appearance of phenotypes such as clumping or alterations in pilus expression highlights the role of residues in interactions within type 1 pili, the in vitro measured phenotype that correlates best with in vivo virulence is the optical tweezer experiments. Note, that we have now removed results of the mutant E121R, which had the most clumping phenotype (see below).

> Further detail can be found in the separate reviews below. If you have any questions about the revisions, please let us know.
>
> Reviewer \#1:
>
> The only concern of this reviewer is that some leaps are made to correlate observations in vitro, with those in vivo. The suggestion that the spring-like qualities of the pilus rod are critical for pathogenesis is entirely possible, but is far from proven.

Please see response to essential revision 1.

> Moreover, few specifics are provided that relate the actual shear forces of urine at various distances from the mucosal boundary to the forces measured for variations in the protein.

Urine flow in the urinary tract is indeed complex and hash: boluses are transported from the kidney to the bladder via peristaltic motion; and high fluid flow exposes bacterial cells to high shear forces during expulsion of urine from the bladder. In addition, peristaltic motion creates shear forces that include reversal wall shear forces and normal forces. Bacteria need to attach and adhere in these conditions, which implies that they are not more than a "coiled-pili-length" away from the surface. Therefore, the shear forces, which increase more-or-less linearly with height for small displacement, will not be significantly different at various distances from the mucosal boundary. This implies also for flow chamber experiments.

Several flow chamber experiments generating shear stress of similar magnitude as physiological conditions (Busscher and van der Mei, 2006) have been performed (Aprikian et al., 2011; Rangel et al., 2013)). Interestingly, these experiments exposed cells from low to high forces, that is, from 10 -- 140 pN (Aprikian et al., 2011), which is in the range of WT type 1 pili uncoiling. Pili uncoiling for WT bacteria, leading to bacterial displacement of the order of a few micrometers, have also been demonstrated in flow chamber experiments. Thus experiments support that shear forces exposing bacteria within physiological conditions are sufficiently to uncoil WT pili (Rangel et al., 2013). Since we measured lower uncoiling force for the mutants, we expect that these "softer-spring" pili attaching bacteria to cells will not be able to modulate and dampen the fluid forces as good as WT pili. This reduced damping capability will therefore make it harder for bacteria to attach and adhere.

> A number of uncontrolled variables could explain why mutant variants of the protein are less effective in vivo, including increased susceptibility to tissue resident proteases, altered interactions with various elements of the mucosa, altered physical states imposed (such as the clumping that was observed), etc. While an interesting prospect, the mechanical properties proposed could be explored further for proof, or the discussion of this prospect modified in the text (although the latter arguably could affect the perceived impact of the study in altering existing paradigms).

Please see response to essential revisions 1 and 2.

> Aside from that concern, this reviewer found the paper to be of considerable interest and well done.
>
> Reviewer \#2:
>
> \[...\] 1) The A22R mutant has a significant defect at 6 hours in the mouse. Does this mutant affect the ability of bacteria to invade the superficial facet cells?

This is an important point. To address this question we now include data regarding the ability of the A22R mutant to invade into bladder tissue at 1, 3, and 6 hours. This was done via gentamycin protection assays. We found that the A22R mutant does indeed have an invasion defect compared to WT starting at 1 hpi. This ability of this strain to persist in the lumen of the bladder is also attenuated compared to WT. We have added this invasion data to [Figure 5](#fig5){ref-type="fig"} as panel G.

> 2\) A few of the mutants were tested in vivo, but not in vitro. For example, E123R was tested in the mouse and displayed a defect in acute and chronic UTI (and a slight defect in gut colonization), but the force measurements for unwinding this pili were not determined.

Thank you for pointing this out. The E123R mutant was not included in the optical tweezer data due to difficulty in obtaining reading with single pili attached the beads. The attachment of a single pilus to a bead is essential for us to calculate an accurate unwinding force measurement. After multiple additional failed attempts to acquire this data for this FimA mutant, we have decided to remove all analysis of this mutant from the paper.

> Reviewer \#3:
>
> \[...\] 1) Measurement of the unwinding force.a) The authors state in the Materials and methods part they expect \"attachment a few pili with the microsphere\". Determination of the unwinding force, however, is only possible it the authors can make sure that only a single pilus is attached at the time.

We thank the reviewer for bringing this issue to our attention. Based on this comment, it is clear that our description of the molecular tweezers experiment in the Materials and methods section did not clearly explain how the force-spectroscopy measurements were taken. Therefore, we have now included additional text in the Materials and methods to clarify the experimental set up for this method. Further, we have included an additional figure ([Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}) that better explains how we assessed the data when multi-pili interactions to the bead occur. Further explanation of multi-pili attachment to microspheres and analysis of force curves can be found in references (Andersson et al., 2008; Castelain et al.; Fallman et al., 2005; Jass et al., 2004; Mortezaei et al., 2015).

The new text reads:

"A free-floating bacterium was trapped by the optical tweezers run at low power to avoid cell damage. \[...\] Finally, we controlled the piezo-stage and sampled the data using an in-house LabView program (Andersson, 2017)."

> b\) I haven\'t found any information about how the mutations analysed in [Figure 4B](#fig4){ref-type="fig"} affect the number of pili per cell. If more than a pilus is bound during a force measurement, then the level of piliation can affect the measured uncoiling force.

Thank you for this comment, we have provided additional text in the Materials and methods section that explicitly states our use of only a single pilus to make any force measurements. Please see response above to point 1a.

> c\) Only technical replicates from a single sample are inacceptable. Data should be acquired on biological replicates on at least three different days.

This is an excellent and critical point made by the reviewer. We have included additional data into [Figure 4](#fig4){ref-type="fig"} to ensure that biological replicates from different days are shown.

> 2\) Expression levels and functionality of pili with point mutations.
>
> The authors state that \"FimA mutant strain produced minimal changes to the levels of type 1 piliation \[...\] and to the function of the type 1 pilus\". The experimental data supporting this statement is shown in [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}. I cannot understand this statement based on the data. The percentage of \"bald\" bacteria is about 3x higher for the D116R strain compared to wt. The mannose-inhibitable HA-titre is about 10x higher in the E123R and D116R strains compared to wt. We can expect that the pilus density affects host-pathogen interactions. One way of showing that the 3x increase of pilus density does not affect the conclusion, would be to generate strains with wt fimA sequence but decreased pilus levels.

In order to better characterize the variability that we observe in pilus expression with each mutant, we have altered the text in the manuscript to more explicitly reflect the data presented in [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}. However, we feel that our overall statement that indicated FimA mutants do not prevent the expression or function of type 1 pili in vitrois demonstrated.

This text now reads:

"When compared to a strain with the reintegrated WT UTI89 fimA sequence, we found that all reintegrated FimA mutant strains demonstrated similar levels of GP-RBC agglutination, in vitro ([Figure 5---figure supplement 1C](#fig5s1){ref-type="fig"}),despite some variability in the level of piliation between FimA mutant strain ([Figure 5---figure supplement 1B](#fig5s1){ref-type="fig"}).\[...\] Overall, these findings indicate that the identified FimA mutations do not prevent the expression or function of type 1 pili in vitro."

> 3\) Comparison between different strains.a) The authors explain that they used different bacterial strains with different fimA sequences. This is probably fine, but the way the data is presented now, I get confused with the different notations of the point mutations. For example, is the A22R mutation in [Figure 4B](#fig4){ref-type="fig"} comparable to A24R in [Figure 5G](#fig5){ref-type="fig"}? Same for D114R and D116R etc.? Can the authors come up with a smart way of indicating these connections within the figures?

This is an excellent point that was made by multiple reviewers. In order to prevent confusion, we have chosen to refer to all residues from both strains using the BW25113 number system.

We have also addressed this change in the text:

"Thus, we do note that FimA~UTI89~ differs from our cryo-EM rod FimA~BW25113~ sequence in 16 residues, with all of the differences lying within highly variable residues located on the exterior of the pilus rod, including two additional amino acids at the N-terminus. \[...\] To avoid confusion herein all residues are discussed using the BW25113 numbering system."

[^1]: These authors contributed equally to this work.
